Sera Prognostics Inc.
Organization details
- Legal name
- Sera Prognostics Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 8071 — Services-Medical Laboratories
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Salt Lake City
- Headquarters state / province
- Utah
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- SERA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001534969
- EIN
- 26-1911522
Board of directors
-
Gregory C. Critchfield · Director · Chief Executive OfficerSince 2023
-
Jane F. Barlow · DirectorSince 2023
-
Jeffrey Thomas Elliott · DirectorSince 2025
-
Joshua Phillips · DirectorSince 2023
-
Kim P. Kamdar · DirectorSince 2023
-
Mansoor Raza Mirza · DirectorSince 2023
-
Marcus Dean Wilson · DirectorSince 2024
-
Mark Christopher Capone · DirectorSince 2026
-
Ryan Trimble · DirectorSince 2023
-
Sandra Aj Lawrence · DirectorSince 2023
-
Zhenya Lindgardt · Director · Chief Executive OfficerSince 2023
Chief executives
Director election results
Annual meeting of June 4, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
76.1%
-
97.4%
Board connections
4 of this board's directors also sit on 6 other boards. 2 are in the same sector.
- via Sandra Aj Lawrence
- via Sandra Aj Lawrence
-
ICON plc Same sectorvia Jeffrey Thomas Elliott
-
Karyopharm Therapeutics Inc. Same sectorvia Mansoor Raza Mirza
- via Mark Christopher Capone
- via Jeffrey Thomas Elliott
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $530,867
- 44 sales by 10 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 12, 2026 | Inglis Tiffany Eul Davis Officer (Chief Medical Officer) | Open-market sale | −8,024 | $2.03 | $16,289 |
| Sep 10, 2026 | Anderson Dyaarl Lee Jr. Officer (Chief Commercial Officer) | Open-market sale | −1,800 | $2.00 | $3,600 |
| Sep 10, 2026 | Inglis Tiffany Eul Davis Officer (Chief Medical Officer) | Open-market sale | −486 | $2.00 | $972 |
| Sep 10, 2026 | Jackson Benjamin Officer (General Counsel) | Open-market sale | −2,190 | $2.00 | $4,380 |
| Sep 10, 2026 | Zhenya Lindgardt Director, Officer (Chief Executive Officer) | Open-market sale | −7,022 | $2.00 | $14,044 |
| Sep 8, 2026 | Zhenya Lindgardt Director, Officer (Chief Executive Officer) | Open-market sale | −20,139 | $2.00 | $40,278 |
| Aug 31, 2026 | Gleason Scott Officer (Chief Financial Officer) | Grant or award | +117,924 | — | — |
| Jul 10, 2026 | Jane F. Barlow Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Gregory C. Critchfield Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Mark Christopher Capone Director | Grant or award | +42,404 | — | — |
| Jul 10, 2026 | Kim P. Kamdar Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Sandra Aj Lawrence Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Mansoor Raza Mirza Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Joshua Phillips Director | Grant or award | +22,426 | — | — |
| Jul 10, 2026 | Jane F. Barlow Director | Grant or award | +1,949 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Sera Prognostics Inc.
Who is the CEO of Sera Prognostics Inc.?
Gregory C. Critchfield is Sera Prognostics Inc.'s Chief Executive Officer.
How many directors are on Sera Prognostics Inc.'s board?
Sera Prognostics Inc.'s board has 11 directors: Gregory C. Critchfield, Jane F. Barlow, Jeffrey Thomas Elliott, Joshua Phillips, Kim P. Kamdar, Mansoor Raza Mirza, Marcus Dean Wilson, Mark Christopher Capone, Ryan Trimble, Sandra Aj Lawrence and 1 other.
Are Sera Prognostics Inc. insiders buying or selling shares?
Over the last 12 months, Sera Prognostics Inc. insiders made no open-market purchases and sold $530,867 of shares in 44 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="sera-prognostics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.